RESOLUTE and REsolution Final Conference on 27-29 September 2023
From 27 to 29 September 2023, the 'Unlocking Transporters for Drug Discovery' Conference took place at the historic Palais Niederösterreich in Vienna, Austria. The event, open for the first time to the entire scientific community, marked the conclusion of the RESOLUTE and REsolution projects, which are set to conclude by the end of 2023.
The REsolution and RESOLUTE consortia are public-private research partnerships supported by the Innovative Health Initiative (IHI), the European Union, and EFPIA. They are coordinated by CeMM and Pfizer and include partners from academia and the pharmaceutical industry. The RESOLUTE project aims to intensify global research on solute carrier (SLC) transporters and establish them as a novel target class for medical research, while the REsolution project aims to understand how genetic variants in humans affect the function of cellular SLCs.
Approximately 200 participants attended the scientific conference, which featured an engaging program including 45 top international scientists, with 20 external speakers from outside the consortia. The program also included two poster sessions with 60 abstract presenters. During the event, the RESOLUTE and REsolution consortia presented the results and lessons learned over the past five years to the broader scientific community. The talks covered various topics related to molecular transporters, their role in cell metabolism and regulation, structural biology, drug discovery, data integration, systems biology, as well as human physiology and disease.
The conference's theme was 'Fun Fair.' Participants had the opportunity to participate in various activities, including a virtual reality booth to explore the project's data, games organized by Nanion and Genscript, as well as a theater play featuring 'Transpy and Porty.'
We extend our gratitude to all participants for joining the event and engaging in meaningful scientific exchanges with other scientists and partners. Special thanks to Boehringer Ingelheim, Pfizer, and Sanofi for their support!
Stay updated with project news at https://re-solute.eu/